A retrospective case series of patients who have undergone coeliac plexus blocks for the purpose of alleviating pain due to intra-abdominal malignancy.

Dumitrescu, A; Aggarwal, A; Chye, R

A retrospective case series of patients who have undergone coeliac plexus blocks for the purpose of alleviating pain due to intra-abdominal malignancy.

Dumitrescu, A Aggarwal, A Chye, R

Permalink

Publisher:: Wiley Open Access
Publication Type:: Journal Article
Citation:: Cancer Reports, 2020, 3, (5), pp. e1265-e1265
Issue Date:: 2020-10

Closed Access

	Filename	Description	Size
	cnr2.1265.pdf	Published version	659.49 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Dumitrescu, A
dc.contributor.author	Aggarwal, A
dc.contributor.author	Chye, R
dc.date.accessioned	2021-04-14T00:23:05Z
dc.date.available	2020-06-19
dc.date.available	2021-04-14T00:23:05Z
dc.date.issued	2020-10
dc.identifier.citation	Cancer Reports, 2020, 3, (5), pp. e1265-e1265
dc.identifier.issn	2573-8348
dc.identifier.issn	2573-8348
dc.identifier.uri	http://hdl.handle.net/10453/148076
dc.description.abstract	<h4>Background</h4>Coeliac plexus block (CPB) is an interventional pain management option for patients with pancreatic or other upper abdominal malignancy.<h4>Aims</h4>To assess the safety, utilization, and outcomes of CPBs in the local context.<h4>Methods and results</h4>We conducted a retrospective case series of all patients with cancer who underwent CPB at 4 Sydney teaching hospitals from March 2010 to February 2016. We recorded baseline demographic data, details of the injectate, procedural approach and survival, as well as pain scores and analgesic use at 4 time points of interest. Thirty-nine procedures were performed during the study period. Twenty-four were performed endoscopically, 14 were performed via a bilateral percutaneous posterior approach by Pain Specialists or Radiologists and 1 was performed intraoperatively by a Surgeon. Patients had experienced pain for a mean of 17 weeks prior to CPB. Prior to CPB, the mean pain score was 8.8 out of 10. The mean pain score was reduced at 48 hours, 2 weeks, and 4 weeks following CPB (P < .01). The mean oral morphine equivalent daily dose prior to CPB was 362 mg which was reduced at 48 hours and 2 weeks but increased at the 4 weeks following CPB. One patient developed a bacteremia but otherwise no complications were observed.<h4>Conclusion</h4>CPB is performed by a number of approaches and is well tolerated. The approach selected appears to depend on patient anatomy, preference, and availability of local expertise. Local clinicians could consider CPB earlier in the management of malignant epigastric pain.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Wiley Open Access
dc.relation.ispartof	Cancer Reports
dc.relation.isbasedon	10.1002/cnr2.1265
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	A retrospective case series of patients who have undergone coeliac plexus blocks for the purpose of alleviating pain due to intra-abdominal malignancy.
dc.type	Journal Article
utslib.citation.volume	3
utslib.location.activity	United States
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
pubs.consider-herdc	true
dc.date.updated	2021-04-14T00:23:04Z
pubs.issue	5
pubs.publication-status	Published
pubs.volume	3
utslib.citation.issue	5

Abstract:

Background

Coeliac plexus block (CPB) is an interventional pain management option for patients with pancreatic or other upper abdominal malignancy.

Aims

To assess the safety, utilization, and outcomes of CPBs in the local context.

Methods and results

We conducted a retrospective case series of all patients with cancer who underwent CPB at 4 Sydney teaching hospitals from March 2010 to February 2016. We recorded baseline demographic data, details of the injectate, procedural approach and survival, as well as pain scores and analgesic use at 4 time points of interest. Thirty-nine procedures were performed during the study period. Twenty-four were performed endoscopically, 14 were performed via a bilateral percutaneous posterior approach by Pain Specialists or Radiologists and 1 was performed intraoperatively by a Surgeon. Patients had experienced pain for a mean of 17 weeks prior to CPB. Prior to CPB, the mean pain score was 8.8 out of 10. The mean pain score was reduced at 48 hours, 2 weeks, and 4 weeks following CPB (P < .01). The mean oral morphine equivalent daily dose prior to CPB was 362 mg which was reduced at 48 hours and 2 weeks but increased at the 4 weeks following CPB. One patient developed a bacteremia but otherwise no complications were observed.

Conclusion

CPB is performed by a number of approaches and is well tolerated. The approach selected appears to depend on patient anatomy, preference, and availability of local expertise. Local clinicians could consider CPB earlier in the management of malignant epigastric pain.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/148076